85 related articles for article (PubMed ID: 1399946)
1. In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniae.
Fremaux A; Sissia G; Cohen R; Geslin P
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():19-23. PubMed ID: 1399946
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria.
Brumfitt W; Hamilton-Miller JM; Shah S
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():29-37. PubMed ID: 1399948
[TBL] [Abstract][Full Text] [Related]
3. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
Nakashio S; Iwasawa H; Iino S; Shimada J
Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
[TBL] [Abstract][Full Text] [Related]
4. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Sep; 38(9):2065-72. PubMed ID: 7811020
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
Lozniewski A; Lion C; Mory F; Weber M
Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
[TBL] [Abstract][Full Text] [Related]
6. [In vitro antibacterial activity of pristinamycin against penicillin resistant Streptococcus pneumoniae].
Fremaux A; Sissia G; Geslin P
Pathol Biol (Paris); 1993 Sep; 41(7):636-40. PubMed ID: 8255615
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae.
Reinert RR; Kresken M; Mechery V; Lemperle M; Lütticken R
Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):662-5. PubMed ID: 9832271
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci.
Pechère JC
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():15-8. PubMed ID: 1399945
[TBL] [Abstract][Full Text] [Related]
9. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies.
Pankuch GA; Lichtenberger C; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Jul; 40(7):1653-6. PubMed ID: 8807057
[TBL] [Abstract][Full Text] [Related]
10. In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500.
Bouanchaud DH
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():95-9. PubMed ID: 1399956
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and enterococci.
Johnson CC; Slavoski L; Schwartz M; May P; Pitsakis PG; Shur AL; Levison ME
Diagn Microbiol Infect Dis; 1995 Mar; 21(3):169-73. PubMed ID: 7648837
[TBL] [Abstract][Full Text] [Related]
12. In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
Dubois J; Joly JR
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():77-81. PubMed ID: 1399954
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens.
Barry AL; Fuchs PC
Antimicrob Agents Chemother; 1995 Jan; 39(1):238-40. PubMed ID: 7695313
[TBL] [Abstract][Full Text] [Related]
14. A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France.
Soussy CJ; Acar JF; Cluzel R; Courvalin P; Duval J; Fleurette J; Megraud F; Meyran M; Thabaut A
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():53-8. PubMed ID: 1399951
[TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of pristinamycin against Streptococcus pneumoniae].
Maugein J; Rakoto-Alson O; Fourche J; Launay C;
Pathol Biol (Paris); 2001 Sep; 49(7):583-6. PubMed ID: 11642023
[TBL] [Abstract][Full Text] [Related]
16. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
[TBL] [Abstract][Full Text] [Related]
17. Activity of telithromycin against erythromycin-susceptible and -resistant Streptococcus pneumoniae isolates from adults with invasive infections.
Ortega M; Marco F; Almela M; Puig J; Soriano A; Mensa J
Int J Antimicrob Agents; 2004 Dec; 24(6):616-8. PubMed ID: 15555888
[TBL] [Abstract][Full Text] [Related]
18. [The phenotype and genotype patterns of erythromycin-resistant Streptococcus pneumoniae].
Zhao TM; Liu YN
Zhonghua Nei Ke Za Zhi; 2004 May; 43(5):329-32. PubMed ID: 15182500
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies.
Hoban DJ; Weshnoweski B; Palatnick L; Zhanel CG; Davidson RJ
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():59-65. PubMed ID: 1399952
[TBL] [Abstract][Full Text] [Related]
20. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
